Branded vial and pen-kit presentation. Confirm the available format, contents and packaging for this product.
TB-500
A thymosin beta-4-related research material; sequence and identity are batch-specific.
Listed content per unit- Presentation
- Vial presentation
- Local dispatch markets
- Australia · Canada · USA
- Availability
- Confirm by strength & location
- Documentation
- Request product & batch records
For qualified research enquiries. Listed content is not a dose or administration instruction.
The research context
TB-500 is a name used for thymosin-beta-4-related research materials. Molecular identity matters: analytical literature has identified an acetylated peptide fragment, whereas other research examines full-length thymosin beta-4.
Request the sequence and batch identity. Results for full-length thymosin beta-4 cannot automatically be applied to a material sold under the TB-500 name.
What does TB-500 do?
Read our TB-500 guide for a simple explanation of recovery and tissue research and what studies found.
What to include in your enquiry
Tell us your required compound, strength, presentation and destination country. If you have a particular analytical requirement, include the method or document you need so the team can match your request to the relevant specification.
Selected scientific references
These sources describe published research or a specific regulated medicine. They are not certificates for an Aurelis batch.
Explore related entries.
All compoundsBPC-157
A synthetic peptide studied in preclinical models of tissue response and repair.
GHK-Cu
A copper-binding tripeptide investigated in extracellular matrix and skin biology.
Connect with Aurelis
Your next enquiry
starts with the details.
Tell us the compound, listed content, preferred presentation and destination. Our team can discuss local availability and the documentation for your selected material.